Seres Therapeutics Inc (MCRB) stock news · rev $789.0K
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
This MCRB news page leads with what Seres Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for MCRB yet. We will not pad this page with generic market recap.
Latest reported MCRB revenue for 2025-12-31 was $789.0K. Net income was $5.7M. MCRB currently screens at market cap $109.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MCRB stock page; for the tape open the quote page.
MCRB stock news FAQ
What are MCRB's latest revenue and net income?
Latest cached Seres Therapeutics Inc (MCRB) revenue for Dec 31, 2025 was $789.0K. Net income was $5.7M. Statements: https://lician.com/financials/mcrb
What is MCRB's market cap?
Seres Therapeutics Inc (MCRB) market cap is $109.8M on the latest cached fundamentals snapshot.
What kind of company is MCRB?
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Where is MCRB stock news listed?
Cached stock news for Seres Therapeutics Inc (MCRB) is listed at https://lician.com/news/mcrb. Filings: https://lician.com/sec/mcrb
Not investment advice.